Atritech Inc.
This article was originally published in Start Up
Executive Summary
Atritech Inc. is developing a minimally invasive device to prevent harmful-sized emboli from exiting the left atrial appendage. It believes that its Watchman filter will be just as effective as warfarin in preventing strokes in AF patients.